Study: NCT03334851

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06835375
Description: Intravenous (IV) or subcutaneous (SC) administration. Subjects will receive one or two doses. Doses will be ascending and determined by emerging data.